Cargando…
Persistently Elevated Plasma Concentrations of RIPK3, MLKL, HMGB1, and RIPK1 in Patients with COVID-19 in the Intensive Care Unit
Autores principales: | Ruskowski, Katharina, Neb, Holger, Talbot, Steven R., Choorapoikayil, Suma, Adam, Elisabeth H., von Knethen, Andreas, Zacharowski, Kai, Heinicke, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447136/ https://www.ncbi.nlm.nih.gov/pubmed/35385375 http://dx.doi.org/10.1165/rcmb.2022-0039LE |
Ejemplares similares
-
RIPK1–RIPK3–MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils
por: Barbosa, Laiana A., et al.
Publicado: (2018) -
RIPK1-RIPK3-MLKL-dependent necrosis promotes the aging of mouse male reproductive system
por: Li, Dianrong, et al.
Publicado: (2017) -
TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer
por: Lin, Penghang, et al.
Publicado: (2023) -
Necroptosis induced by RIPK3 requires MLKL but not Drp1
por: Moujalled, D M, et al.
Publicado: (2014) -
Furosine, a Maillard Reaction Product, Triggers Necroptosis in Hepatocytes by Regulating the RIPK1/RIPK3/MLKL Pathway
por: Li, Huiying, et al.
Publicado: (2019)